AVITA Medical to Announce Third Quarter 2025 Financial Results
AVITA Medical (NASDAQ: RCEL) will report third quarter 2025 financial results after U.S. market close on Thursday, November 6, 2025. The company will host a conference call and webcast the same day at 1:30 p.m. Pacific Time (Friday, November 7, 2025 at 8:30 a.m. Australian Eastern Daylight Time) to discuss results and recent business highlights.
The live webcast will be available in the Events & Presentations section of AVITA Medical's investor website at ir.avitamedical.com. Telephone participants must register in advance to receive dial-in details and a personal PIN; a replay will be posted on the investor site shortly after the live event.
AVITA Medical (NASDAQ: RCEL) riferirà i risultati finanziari del terzo trimestre 2025 dopo la chiusura del mercato US il giovedì 6 novembre 2025. L'azienda terrà una conference call e trasmetterà in webcast lo stesso giorno alle 13:30 ora del Pacifico (venerdì 7 novembre 2025 alle 8:30 ora dell'Australian Eastern Daylight Time) per discutere i risultati e i principali aggiornamenti aziendali.
Il webcast live sarà disponibile nella sezione Eventi & Presentazioni del sito degli investitori di AVITA Medical all'indirizzo ir.avitamedical.com. I partecipanti telefonici devono registrarsi in anticipo per ricevere i dettagli di dial-in e un PIN personale; una replica sarà pubblicata sul sito degli investitori poco dopo l'evento live.
AVITA Medical (NASDAQ: RCEL) reportará los resultados financieros del tercer trimestre de 2025 tras el cierre de los mercados de EE. UU. el jueves 6 de noviembre de 2025. La compañía celebrará una conferencia telefónica y transmitirá por webcast el mismo día a las 1:30 p.m. hora del Pacífico (viernes 7 de noviembre de 2025 a las 8:30 a.m. hora de Australian Eastern Daylight Time) para discutir los resultados y los principales aspectos comerciales recientes.
El webcast en vivo estará disponible en la sección Eventos y presentaciones del sitio web de inversores de AVITA Medical en ir.avitamedical.com. Los participantes por teléfono deben registrarse con anticipación para recibir los detalles de marcación y un PIN personal; una repetición estará publicada en el sitio de inversores poco después del evento en vivo.
AVITA Medical (나스닥: RCEL)은 2025년 3분기 재무 실적을 미국 시장 마감 후 2025년 11월 6일 목요일에 발표합니다. 회사는 같은 날 태평양 표준시 13:30의 컨퍼런스 콜을 주최하고 동시 webcast를 시작하며 (2025년 11월 7일 금요일에 호주 동부 표준시/일광시간 해제 시간 8:30) 결과 및 최근 사업 하이라이트를 논의합니다.
라이브 웨비나는 AVITA Medical의 투자자 웹사이트의 Events & Presentations 섹션에서 이용 가능하며 ir.avitamedical.com에서 확인할 수 있습니다. 전화 참여자는 다이얼 인 세부 정보와 개인 PIN을 받기 위해 사전에 등록해야 하며, 라이브 이벤트 직후 투자자 사이트에 녹화본이 게시됩니다.
AVITA Medical (NASDAQ: RCEL) affichera les résultats financiers du troisième trimestre 2025 après la clôture du marché américain le jeudi 6 novembre 2025. L'entreprise organisera une conférence téléphonique et diffusera par webcast le même jour à 13h30, heure du Pacifique (vendredi 7 novembre 2025 à 8h30, heure de l'Australian Eastern Daylight Time) pour discuter des résultats et des points marquants récents de l'activité.
Le webcast en direct sera disponible dans la section Événements et présentations du site Web des investisseurs d'AVITA Medical à l'adresse ir.avitamedical.com. Les participants téléphoniques doivent s'inscrire à l'avance pour recevoir les détails de connexion et un code PIN personnel; une rediffusion sera publiée sur le site des investisseurs peu après l'événement en direct.
AVITA Medical (NASDAQ: RCEL) wird die Finanzergebnisse des dritten Quartals 2025 nach Börsenschluss in den USA am Donnerstag, dem 6. November 2025 bekannt geben. Das Unternehmen wird am selben Tag eine Telefonkonferenz abhalten und den Webcast um 13:30 Uhr Pazifikzeit übertragen (Freitag, der 7. November 2025 um 8:30 Uhr Australische Östliche Sommerzeit), um Ergebnisse und aktuelle Geschäftsschwerpunkte zu erörtern.
Der Live-Webcast ist im Bereich Events & Präsentationen der AVITA Medical-Investorenseite unter ir.avitamedical.com verfügbar. Telefonteilnehmer müssen sich im Voraus registrieren, um Dial-in-Details und eine persönliche PIN zu erhalten; eine Aufnahme wird kurz nach der Live-Veranstaltung auf der Investorenseite veröffentlicht.
AVITA Medical (بورصة ناسداك: RCEL) سيعلن عن نتائج الربع الثالث من عام 2025 بعد إغلاق السوق الأمريكية في يوم الخميس 6 نوفمبر 2025. ستعقد الشركة مكالمة مؤتمر وتبث عبر الويب في نفس اليوم في 1:30 مساءً بتوقيت المحيط الهادئ (الجمعة 7 نوفمبر 2025 في 8:30 صباحًا بتوقيت شرق أستراليا الصيفي) لمناقشة النتائج وأهم التطورات الأخيرة في الأعمال.
سيكون البث المباشر متاحاً في قسم الأحداث والعروض على موقع AVITA Medical للمستثمرين على ir.avitamedical.com. يجب على المشاركين عبر الهاتف التسجيل مسبقًا لتلقي تفاصيل الاتصال واله PIN الشخصي؛ سيتم نشر إعادة للمقطع على موقع المستثمرين قريبًا بعد الحدث المباشر.
AVITA Medical (纳斯达克股票代码：RCEL) 将在 2025年第三季度 财务业绩披露后于美股收盘后发布新闻公告，时间为 2025年11月6日（星期四）。公司将于同日举行电话电话会议并进行网络直播，时间为 太平洋时间下午1:30（2025年11月7日，星期五，澳大利亚东部夏令时上午8:30），以讨论业绩及近期业务要点。
实时网络广播将在 AVITA Medical 投资者网站的 事件与展示 部分提供，地址为 ir.avitamedical.com。参加电话会议的人员须提前注册以获取拨号详情和个人 PIN；网络直播结束后不久，回放将发布在投资者网站上。
- None.
- None.
VALENCIA, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will report its third quarter 2025 financial results after the close of the U.S. financial markets on Thursday, November 6, 2025. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, November 7, 2025, at 8:30 a.m. Australian Eastern Daylight Time) to discuss its financial results and recent business highlights.
The live webcast will be accessible under the Events & Presentations section of the AVITA Medical website at ir.avitamedical.com. To participate by telephone, please register in advance to receive dial-in details and a personal PIN using the following link: https://edge.media-server.com/mmc/p/fpry6ovp/. A replay of the webcast will be available shortly after the live event on the Investor Relations website.
About AVITA Medical, Inc.
AVITA Medical® is a leading therapeutic acute wound care company delivering transformative solutions. Our technologies are designed to optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of our platform is the RECELL® System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn and trauma wounds. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin™ Cells, offering an innovative solution for improved clinical outcomes at the point-of-care. In the U.S., AVITA Medical also holds the rights to manufacture and exclusive rights to market, sell, and distribute PermeaDerm®, a biosynthetic wound matrix, and the exclusive rights to market, sell, and distribute Cohealyx™, an AVITA Medical-branded collagen-based dermal matrix.
In international markets, the RECELL System is approved to promote skin healing in a wide range of applications including thermal burn and trauma wounds, with regulatory clearances in Europe, and excluding RECELL GO, in Australia and Japan.
To learn more, visit www.avitamedical.com.
Investor & Media Contact:
Ben Atkins
Phone +1-805 341 1571
investor@avitamedical.com
media@avitamedical.com
Authorized for release by the Chief Financial Officer of AVITA Medical, Inc.
FAQ
When will AVITA Medical (RCEL) report Q3 2025 results?
What time is the AVITA Medical (RCEL) earnings call and webcast for Q3 2025?
Where can I watch the AVITA Medical (RCEL) live webcast for Q3 2025?
How do I join the AVITA Medical (RCEL) conference call by phone?
Will a replay of the AVITA Medical (RCEL) Q3 2025 webcast be available?
What will AVITA Medical (RCEL) discuss on the Q3 2025 call?
